Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.
Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Minot Daily News2d
Grant brings free virtual wellness to Parkinson’s Community
The Minot Family YMCA announced it has received a grant from the Parkinson’s Foundation to provide free access to YMCA360, a virtual health and wellness platform, to individuals diagnosed with ...
Daily3d
Multiple penicillin courses may modestly lower risk for Parkinson disease, reveals research
Researchers have reported that early exposure to a few antimicrobials, like penicillins and antifungals, could impact the ...
Business Wire6d
Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...